• 1
    Danishefsky SJ, Allen JR. From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines. Angew Chem Int Ed Engl 2000;39: 83663.
  • 2
    Ragupathi G. Carbohydrate antigens as targets for active specific immunotherapy. Cancer Immunol Immunother 1996;43: 1527.
  • 3
    Kaizu T, Levery SB, Nudelman E, et al. 1986. Novel fucolipids of human adenocarcinoma: monoclonal antibody specific for trifucosyl Ley (III3FucV3FucVI2FucnLc6) and a possible three-dimensional epitope structure. J Biol Chem 1986;261: 112548.
  • 4
    Nudelman E, Levery SB, Kaizu T, et al. 1986. Novel fucolipids of human adenocarcinoma: characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI2FucnLc6). J Biol Chem 1986;261: 1124753.
  • 5
    Kim YS, Yuan M, Itzkowitz SH, et al. Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant and nonmalignant colonic tissues. Cancer Res 1986;46: 598592.
  • 6
    Hellstrom I, Garrigues HJ, Garrigues U, et al. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Lewisy-related cell surface antigens. Cancer Res 1990;50: 218390.
  • 7
    Deshpande PP, Danishefsky SJ. Total synthesis of the potential anticancer vaccine KH-1 adenocarcinoma antigen. Nature 1997;387: 1646.
  • 8
    Deshpande PP, Kim HM, Zatorski A, et al. Strategy in oligosaccharide synthesis: an application to a concise total synthesis of the KH-1 (adenocarcinoma) antigen. J Am Chem Soc 1998;120: 160014.
  • 9
    Hummel G, Schmidt RR. A versatile synthesis of the lactoneo-series antigens- synthesis of sialyl dimer lewisx and of Dimer Lewisy. Tetrahedron Lett 1997;38: 11736.
  • 10
    Kensil CR, Patel U, Lennick M, et al. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol 1991;146: 4317.
  • 11
    Ragupathi G, Koganty RR, Qiu DX, et al. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn KLH conjugate using a 4-(4-N-maleimidomethyl)cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm. Glycoconjugate J 1998;15: 21721.
  • 12
    Ragupathi G, Howard L, Cappello S, et al. 1999. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells. Cancer Immunol Immunother 1999;48: 18.
  • 13
    Ragupathi G, Park TK, Zhang S, et al. Immunization of mice with a fully synthetic globo-H antigen results in antibodies against human cancer cells: a combined chemical-immunological approach to the fashioning of an anticancer vaccine. Angew Chem Int Ed Engl 1997;36: 1258.
  • 14
    Zhang S, Helling F, Lloyd KO, et al. Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides. Cancer Immunol Immunother 1995;40: 8894.
  • 15
    Zhang S, Zhang HS, Cordon-Cardo C, et al. 1997. Selection of tumor antigens as targets for immune attack using immunohistochemistry. II. Blood group-related antigens. Int J Cancer 1997;73: 506.
  • 16
    Capurro M, Bover L, Portela P, et al. A monoclonal antibody active against human breast cancer specifically recognizes Lewis X hapten. Cancer Immunol Immunother 1998;45: 3349.
  • 17
    Cappello S, Liu NX, Musselli C, et al. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells. Cancer Immunol Immunother 1999;48: 48392.
  • 18
    Kabat EA. Antigenic determinants and the size of the antibody-combining site: determinants of cell-mediated immunity. In: KabatEA. Structural concepts in immunology and immunochemistry. New York: Holt, Rinehart and Winston, 1976. 11966.
  • 19
    Livingston PO, Ragupathi G. Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans. Cancer Immunol Immunother 1997;45: 109.
  • 20
    Anderson PW, Pichichero ME, Stein EC, et al. Effect of oligosaccharide chain length, exposed terminal group and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein CRM 197. J Immunol 1989;142: 24648.
  • 21
    Pozsagay V, Chu C, Pannell L, et al. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type1. Proc Natl Acad Sci USA 1999;96: 51947.